nach oben

Erschienen in:

2018 | OriginalPaper | Buchkapitel

24. Hydrops fetalis, Anämie und Thrombozytopenie

verfasst von : Prof. Dr. med. U. Gembruch

Erschienen in: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie

Verlag: Springer Berlin Heidelberg

Einloggen, um Zugang zu erhalten

Zusammenfassung

Hydrops fetalis bezeichnet das Auftreten fetaler Wassereinlagerungen in mindestens zwei fetalen Kompartimenten. Wenn dem eine hämolytische Anämie durch gegen fetale Erythrozyten gerichtete maternale Alloantikörper zugrunde liegt, spricht man von einem immunologisch bedingten Hydrops fetalis (IHF). Die anderen über 150 fetale Erkrankungen umfassenden Ursachen eines Hydrops werden als nicht immunologisch bedingter Hydrops fetalis (NIHF) bezeichnet. Ursache, Diagnostik, Prognose und mögliche Therapie bei Vorliegen eines Hydrops fetalis werden in diesem Kapitel abgehandelt, insbesondere die in der Regel gut zu behandelnden Anämien des Feten. Ferner wird ausführlich auf die Diagnostik und Therapie fetaler Thrombozytopenien eingegangen.

Vorheriges Kapitel Large-for-gestational-age-Feten

Nächstes Kapitel Chromosomale und nicht chromosomale Syndrome

Adzick NS (2009) Management of fetal lung lesions. Clin Perinatol 36: 363–376

Adzick NS (2010) Open fetal surgery for life–threatening fetal anomalies. Semin Fetal Neonatal Med 15: 1–8

Altarescu G, Elda-Geva T, Grisaru-Granovsky S, Bonstein L, Miskin H, Varshver I, Margalioth EJ, Levy-Lahad E, Renbaum P (2012) Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies. Obstet Gynecol 119: 338–343

Amann C, Geipel A, Müller A, Heep A, Ritgen J, Stressig R, Kozlowski P, Gembruch U, Berg C (2011) Fetal anemia of unknown cause – a diagnostic challenge. Ultraschall Med 32 (Suppl 2): E115–E121

Arinsburg SA, Shaz BH, Westhoff C, Cushing MM (2012) Determination of human platelet antigen typing by molecular methods: Importance in diagnosis and early treatment of neonatal alloimmune thrombocytopenia. Am J Hematol 87: 525–528

Bakchoul T, Greinacher A, Sachs UJ, Krautwurst A, Renz H, Harb H, Bein G, Newmann PJ, Santoso S (2013) Inhibition of HPA-1a alloantibody-mediated platelet destructionm by a deglycosylated antii-HPA-1a antibody in mice: toward targeted treatment of fetal-alloimmune thrombocytopenia. Blood 122: 321–327

Bellini C, Hennekam RC, Fulcheri E, Rutigliani M, Morcaldi G, Boccardo F, Bonioli E (2009) Etiology of nonimmune hydrops featlis: a systematic review. Am J Med Genet A 149 (A): 844–851

Bellini C, Donarini G, Paladini D, Calevo MG, Bellini T, Ramenghi LA, Hennekam RC (2015) Etiology of non-immune hydrops fetalis: an update. Am J Med Genet A 167A: 1082–1088

Berkowitz RL, Kolb EA, McFarland JG, Wissert M, Primani A, Lesser M, Bussel JB (2006) Parallel randomized trials of risk–based therapy for fetal alloimmune thrombocytopenia. Obstet Gynecol 107: 91–96

Bertrand G, Drame M, Martageix C, Kaplan C (2011) Prediction of the fetal status in noninvasive management of alloimmune thrombocytopenia. Blood 117: 3209–3213

Bertrand G, Petermann R, Kaplan C (2014) Prediction of IVIG treatment efficiency in fetal/neonatal alloimmune thrombocytopenia. Blood 124: 654–655

Bianchi S, Lista G, Castoldi F, Rustico M (2010) Congenital primary hydrothorax: effect of thoracoamniotic shunting on neonatal clinical outcome. J Matern Fetal Neonatal Med 23: 1225–1229

Boulot P, Cattaneo A, Taib J, Peray P, Lefort G, Hedon B, Laffargue F, Viala JL (1993) Hematologic values of fetal blood obtained by means of cordocentesis. Fetal Diagn Ther 8: 309–316

Braun T, Brauer M, Fuchs I, Czernik C, Dudenhausen JW, Henrich W, Sarioglu N (2010) Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther 27: 191–203

Bussel JB, Sola-Visner M (2009) Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 33: 35–42

Bussel JB, Berkowitz RL, Lynch L, Lesser ML, Paidas MJ, Huang CL, McFarland JG (1996) Antenatal management of alloimmune thrombocytopenia with intravenous gamma-globulin: a randomized trial of the addition of low-dose steroid to intravenous gamma-globulin. Am J Obstet Gynecol 174: 1414–1423

Bussel JB, Berkowitz RL, Hung C, Kolb EA, Wissert M, Primiani A, Tsaur FW, Macfarland JG (2010) Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. Am J Obstet Gynecol 203: 135.e1–135.e14

Cosmi E, Mari G, Delle Chiaie L, Detti L, Akiyama M, Murphy J, Stefos T, Ferguson 2nd JE, Hunter D, Hsu CD, Abuhamad A, Bahado-Singh R (2002) Noninvasive diagnosis by Doppler ultrasonography of fetal anemia resulting from parvovirus infection. Am J Obstet Gynecol 187: 1290–1293

Courtier J, Schauer GM, Parer JT, Regenstein AC, Callen PW, Glenn OA (2012) Polymicrogyria in a fetus with human parvovirus B19 infection: a case with radiologic–pathologic correlation. Ultrasound Obstet Gynecol 40: 604–606

de Haan TR, van den Akker ES, Porcelijn L, Oepkes D, Kroes AC, Walther FJ (2008) Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load. BJOG 115: 76–81

de Jong EP, Walther FJ, Kroes AC, Oepkes D (2011) Parvovirus B19 infection in pregnancy: new insights and management. Prenat Diagn 31: 419–425

de Jong EP, Lindenburg IT, van Klink JM, Oepkes D, van Kamp IL, Walther FJ, Lopriore E (2012) Intrauterine transfusion for parvovirus B19 infection: long-term neurodevelopmental outcome. Am J Obstet Gynecol 206: 204. e1–204.e5

Detti L, Mari G (2003) Noninvasive diagnosis of fetal anemia. Clin Obstet Gynecol 46: 923–930

Detti L, Oz U, Guney I, Ferguson JE, Bahado-Singh RO, Mari G (2001) Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses: Doppler ultrasound velocimetry for timing the second intrauterine transfusion in fetuses with anemia from red cell alloimmunization. Am J Obstet Gynecol 185: 1048–1051

Detti L, Mari G, Akiyama M, Cosmi E, Moise Jr KJ, Stefor T, Conaway M, Deter R (2002) Longitudinal assessment of the middle cerebral artery peak systolic velocity in healthy fetuses and in fetuses at risk for anemia. Am J Obstet Gynecol 187: 937–939

Dijkmans AC, de Jong EP, Dijkmans BA, Lopriore E, Vossen A, Walther FJ, Oepkes D (2012) Parvovirus B19 in pregnancy: prenatal diagnosis and management of fetal complications. Curr Opin Obstet Gynecol 24: 95–101

Fasano RM (2016) Hemolytic disease of the fetus and newborn in the molecular era. Semin Fetal Neonatal Med 21: 28–34

Gembruch U (2009) Fetal tachyarrhythmia. In: Yagel S, Silverman NH, Gembruch U (eds) Fetal cardiology, 2nd ed. Informa Healthcare, New York, p 461–481

Gembruch U, Holzgreve W (2000) The fetus with nonimmune hydrops. In: Harrison MR, Evans MI, Adzick NS, Holzgreve W (eds) The unborn patient: the art and science of fetal therapy, 3rd ed. Saunders, Philadelphia, p 525–582

Gembruch U, Holzgreve W (2009) Cardiac diseases in association with hydrops fetalis. In: Yagel S, Silverman NH, Gembruch U (eds) Fetal cardiology, 2nd ed. Informa Healthcare, New York, p 483–514

Ghevaert C, Wilcox DA, Fang J, Armour KL, Clark MR, Ouwehand WH, Williamson LM (2008) Developing recombinant HPA-1-a-specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. J Clin Invest 118: 2929–2935

Gimovsky AC, Luzi P, Berghella V (2015) Lysosomal storage disease as an etiology of nonimmune hydrops. Am J Obstet Gynecol 212: 281–290

Gottschalk I, Gottschalk L, Stressig R, Ritgen J, Herberg U, Breuer J, Oberhoffer R, Willruth A, Strizek B, Geipel A, Gembruch U, Berg C (2017a) Ebstein’s anomaly of the tricuspid valve in the fetus – a multicenter experience. Ultraschall Med 38: 427–436

Gottschalk I, Jehle C, Herberg U, Breuer J, Brockmeier K, Bennink G, Hellmund A, Strizek B, Gembruch U, Geipel A, Berg C (2017b) Prenatal diagnosis of absent pulmonary valve syndrome from the 1st trimester onward: novel insights into pathophysiology, associated conditions and outcome of a rare cardiac defect. Ultrasound Obstet Gynecol 49: 637–642

Gumuscu B, Thompson EI, Grovas AC, Zach TL, Warkentin PI, Coccia PF (2013) Successful unrelated cord blood transplantation for homozygous α-thalassemia. J Pediatr Hematol Oncol 35: 570–572

Hudecova I, Chiu RW (2017) Non-invasive prenatal diagnosis of thalassemias using maternal plasma cell free DNA. Best Pract Res Clin Obstet Gynaecol 39: 63–73

Hellmund A, Berg C, Rösing B, Gembruch U, Geipel A (2012) Masked anemia due to cardiac tamponade in a hydropic fetus caused by placental chorioangioma. Ultrasound Obstet Gynecol 39: 479–480

Hellmund A, Berg C, Geipel A, Bludau M, Heydweiller A, Bachour H, Müller A, Müller A, Gembruch U (2016) Prenatal diagnosis and evaluation of sonographic predictors for intervention and adverse outcome in congenital pulmonary airway malformation. PLoS One 11:e0150474.

Hellmund A, Berg C, Geipel A, Bald R, Gembruch U (2017) Early intrauterine transfusion in fetuses with severe anemia caused by parvovirus B19 infection. Fetal Diagn Ther. doi: 10.1159/000477208

Huhta JC (2009) Congestive heart failure in the fetus. In: Yagel S, Silverman NH, Gembruch U (eds) Fetal cardiology, 2nd ed. Informa Healthcare, New York, p 561–578

Jauniaux E, Pahal G, Gervy C, Gulbis B (2000) Blood biochemistry and endocrinology in the human fetus between 11 and 17 weeks of gestation. Reprod Biomed Online 1: 38–44

Kamphuis MM, Oepkes D (2011) Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenat Diagn 31: 712–719

Kamphuis MM, Paridaans N, Porcelijn L, De Haas M, Van Der Schoot CE, Brand A, Bonsel GJ, Oepkes D (2010) Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG 117: 1335–1343

Kamphuis MM, Paridaans NP, Porcelijn L, Lopriore E, Oepkes D (2014) Incidence and consequences of neonatal alloimmune thrombocytopenia: a systematic review. Pediatrics 133: 715–721

Kempe A, Rösing B, Berg C, Kamil D, Heep A, Gembruch U, Geipel A (2007) First-trimester treatment of fetal anemia secondary to parvovirus B19 infection. Ultrasound Obstet Gynecol 29: 226–228

Kjeldsen-Kragh J, Skogen B (2013) Mechanisms and prevention of alloimmunization in pregnancy. Obstet Gynecol Surv 68: 526–532

Kohl T, Van de Vondel P, Stressig R, Wartenberg HC, Heep A, Keiner S, Müller A, Franz A, Fröhlich S, Willinek W, Gembruch U (2009) Percutaneous fetoscopic laser decompression of congenital high airway obstruction syndrome (CHAOS) from laryngeal atresia via a single trocar – current technical constraints and potential solutions for future interventions. Fetal Diagn Ther 25: 67–71

Koyama S, Tomimatsu T, Kanagawa T, Kumasawa K, Tsutsui T, Kimura T (2012) Reliable predictors of neonatal immune thrombocytopenia in pregnant women with idiopathic thrombocytopenic purpura. Am J Hematol 87: 15–21

Krapp M, Kohl T, Simpson JM, Sharland GK, Katalinic A, Gembruch U (2003) Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardia. Heart 89: 913–917

Kreger EM, Singer ST, Witt RG, Sweeters N, Lianoglou B, Lal A, Mackenzie TC, Vichinsky E (2016) Favorable outcomes after in utero transfusion in fetuses with alpha thalassemia major: a case series and review of the literature. Prenat Diagn 36: 1242–1249

Lam YH, Tang MH (2002) Middle cerebral artery Doppler study in fetuses with homozygous alpha-thalassaemia-1 at 12–13 weeks of gestation. Prenat Diagn 22: 56–58

Lamont RF, Sobel JD, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, Uldbjerg N, Romero R (2011) Parvovirus B19 infection in human pregnancy. BJOG 118: 175–186

Le Toriellec E, Chenet C, Kaplan C (2013) Safe fetal platelet genotyping: new developments. Transfusion 53: 1755–1762

Lee FL, Said N, Grikscheit TC, Shin CE, Llanes A, Chmait RH (2012) Treatment of congenital pulmonary airway malformation induced hydrops fetalis via percutaneous sclerotherapy. Fetal Diagn Ther 31: 264–268

Lee HH, Mak AS, Poon CF, Leung KY (2017) Prenatal ultrasound monitoring of homozygous α0-thalassemia-induced fetal anemia. Best Pract Res Clin Obstet Gynaecol 39: 53–62

Leung TY, Lao TT (2012) Thalassaemia in pregnancy. Best Pract Res Clin Obstet Gynecol 26: 37–51

Leung KY, Cheong KB, Lee CP, Chan V, Lam YH, Tang M (2010) Ultrasonographic prediction of homozygous α0–thalassemia using placental thickness, fetal cardiothoracic ratio and middle cerebral artery Doppler: alone or in combination? Ultrasound Obstet Gynecol 35: 149–154

Li DZ, Yang YD (2017) Invasive prenatal diagnosis of fetal thalassemia. Best Pract Res Clin Obstet Gynaecol 39: 41–52

Lindenburg IT, Wolterbeek R, Oepkes D, Klumper FJ, Vandenbussche FP, van Kamp IL (2011) Quality control for intravascular intrauterine transfusion using cumulative sum (CUSUM) analysis for the monitoring of individual performance. Fetal Diagn Ther 29: 307–314

Lindenburg IT, Smits-Wintjens VE, van Klink JM, Verduin E, van Kamp IL, Walther FJ, Schonewille H, Doxiadis II, Kanhai HH, van Lith JM, van Zwet EW, Oepkes D, Brand A, Lopriore E (2012) Long-term neurodevelopmental outcome after intrauterine transfusion for hemolytic disease of the fetus/newborn: the LOTUS study. Am J Obstet Gynecol 206: 141. e1–141.e8

Lindenburg IT, van Klink JM, Smits-Wintjens VE, van Kamp IL, Oepkes D, Lopriore E (2013) Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review. Prenat Diagn 33: 815–822

Lindenburg IT, van Kamp IL, Oepkes D (2014) Intrauterine blood transfusion: current indications and associated risks. Fetal Diagn Ther 36: 263–271

Loh KC, Jelin E, Hirose S, Feldstein V, Goldstein R, Lee H (2012) Microcystic congenital pulmonary airway malformation with hydrops fetalis: steroids vs open fetal resection. J Pediatr Surg 47: 36–39

Mallmann MR, Geipel A, Bludau M, Matil K, Gottschalk I, Hoopmann M, Müller A, Bachour H, Heydweiller A, Gembruch U, Berg C (2016) Bronchopulmonary sequestration with massive pleural effusion: pleuroamniotic shunting vs intrafetal vascular laser ablation. Ultrasound Obstet Gynecol 44: 441–446

Mallmann MR, Graham V, Rösing B, Gottschalk I, Müller A, Gembruch U, Geipel A, Berg C (2017) Thoracoamniotic shunting for fetal hydrothorax: predictors of intrauterine course and postnatal outcome. Fetal Diagn Ther 41: 58–65

Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise Jr KJ, Dorman KF, Ludomirsky A, Gonzalez R, Gomez R, Oz U, Detti L, Copel JA, Bahado- Singh R, Berry S, Martinez-Poyer J, Blackwell SC (2000) Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal redcell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 342: 9–14

Mari G, Zimmermann R, Moise Jr KJ, Deter RL (2005) Correlation between middle cerebral artery peak systolic velocity and fetal hemoglobin after 2 previous intrauterine transfusions. Am J Obstet Gynecol 193: 1117–1120

Mari G, Hanif F, Kruger M, Cosmi E, Santolaya-Forgas J, Treadwell MC (2007) Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses. Ultrasound Obstet Gynecol 29: 310–316

Martí-Carvajal AJ, Peña-Martí GE, Comunián-Carrasco G (2009) Medical treatments for idiopathic thrombocytopenic purpura during pregnancy. Cochrane Database Syst Rev 4: CD007722

Merz WM, Kübler K, Fimmers R, Stoffel-Wagner B, Geipel A, Gembruch U (2012a) Circulating N-terminal pro-B-type natriuretic peptide in fetal anemia before and after treatment. Pediatr Res 72: 174–178

Merz WM, Patzwaldt F, Fimmers R, Stoffel-Wagner B, Gembruch U (2012b) Dual-colour flow cytometry for the analysis of fetomaternal haemorrhage during delivery. J Clin Pathol 65: 186–187

Moise KJ Jr (2008) Management of rhesus alloimmunization in pregnancy. Obstet Gynecol 112: 164–176

Moise KJ Jr, Argoti PS (2012) Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 120: 1132–1139

Moreno CA, Kanazawa T, Barini R, Nomura ML, Andrade KC, Gomes CP, Heinrich JK, Giugliani R, Burin M, Cavalcanti DP (2013) Non-immune hydrops fetalis: a prospective study of 53 cases. Am J Med Genet A161A: 3078–3086

Nicolaides KH, Thilaganathan B, Mibashan RS (1989) Cordocentesis in the investigation of fetal erythropoiesis. Am J Obstet Gynecol 161: 1197–1200

Oepkes D, Seaward PG, Vandenbussche FP, Windrim R, Kingdom J, Beyene J, Kanhai HH, Ohlsson A, Ryan G (2006) DIAMOND Study Group: Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 355: 156–164

Pacheco LD, Berkowitz RL, Moise Jr KJ, Bussel JB, McFarland JG, Saade GR (2011) Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstet Gynecol 118: 1157–1163

Paridaans NP, Kamphuis MM, Taune Wikman A, Tiblad E, van den Akker ES, Lopriore E, Challis D, Westgren M, Oepkes D (2015) Low-dose versus standard-dose intravenous immunglobulin to prevent fetal intracranial hemorrhage in fetal and neonatal alloimmune thrombocytopenia: a randomized trial. Fetal Diagn Ther 38: 147–153

Pasman SA, van den Brink CP, Kamping MA, Adama van Scheltema PN, Oepkes D, Vandenbussche FP (2009) Total blood volume is maintained in nonhydropic fetuses with severe hemolytic anemia. Fetal Diagn Ther 26: 10–15

Picklesimer AH, Oepkes D, Moise Jr KJ, Kush ML, Weiner CP, Harman CR, Baschat AA (2007) Determinants of the middle cerebral artery peak systolic velocity in the human fetus. Am J Obstet Gynecol 197: 526.e1–526.e4

Pistorius LR, Smal J, de Haan TR, Page-Christiaens GC, Verboon-Maciolek M, Oepkes D, de Vries LS (2008) Disturbance of cerebral neuronal migration following congenital parvovirus B19 infection. Fetal Diagn Ther 24: 491–494

Porcelijn L, Van den Akker ES, Oepkes D (2008) Fetal thrombocytopenia. Semin Fetal Neonatal Med 13: 223–230

Rayment R, Brunskill SJ, Soothill PW, Roberts DJ, Bussel JB, Murphy MF (2011) Antenatal interventions for fetomaternal alloimmune thrombocytopenia. Cochrane Database Syst Rev 5: CD004226

Ruano R, Ramalho AS, Cardoso AK, Moise Jr K, Zugaib M (2011) Prenatal diagnosis and natural history of fetuses presenting with pleural effusion. Prenat Diagn 31: 496–499

Scheffer PG, Ait Soussan A, Verhagen OJ, Page-Christiaens GC, Oepkes D, de Haas M, van der Schoot CE (2011a) Noninvasive fetal genotyping of human platelet antigen-1a. BJOG 118: 1392–1395

Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M (2011b) Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 118: 1340–1348

Scheier M, Hernandez-Andrade E, Fonseca EB, Nicolaides KH (2006) Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions. Am J Obstet Gynecol 195: 1550–1556

Schonewille H, Klumper FJ, van de Watering LM, Kanhai HH, Brand A (2007) High additional maternal red cell alloimmunization after Rhesus- and Kmatched intrauterine intravascular transfusions for hemolytic disease of the fetus. Am J Obstet Gynecol 196: 143.e1–143.e6

Serrarens-Janssen VM, Semmekrot BA, Novotny VM, Porcelijn L, Lotgering FK, Delemarre FM, Steegers EA (2008) Fetal/neonatal allo-immune thrombocytopenia (FNAIT): past, present, and future. Obstet Gynecol Surv 63: 239–252

Simms RA, Liebling RE, Patel RR, Denbow ML, Abdel-Fattah SA, Soothill PW, Overton TG (2009) Management and outcome of pregnancies with parvovirus B19 infection over seven years in a tertiary fetal medicine unit. Fetal Diagn Ther 25: 373–378

Slaghekke F, Kist WJ, Oepkes D, Pasman SA, Middeldorp JM, Klumper FJ, Walther FJ, Vandenbussche FP, Lopriore E (2010) Twin anemia-polycythemia sequence: diagnostic criteria, classification, perinatal management and outcome. Fetal Diagn Ther 27: 181–190

Slaghekke F, Pasman S, Veujoz M, Middeldorp JM, Lewi L, Devlieger R, Favre R, Lopriore E, Oepkes D (2015) Middle cerebral artery peak systolic velocity to predict fetal hemoglobin levels in twin anemia-polycythemia sequence. Ultrasound Obstet Gynecol 46: 432–436

SMFM (Society of Maternal-Fetal Medicine); Norton ME, Chauhan SP, Dashe JS (2015a) Society of Maternal-Fetal Medicine (SFMF) Clinical Guideline #7: nonimmune hydrops fetalis. Am J Obstet Gynecol 212: 127–139

SMFM (Society of Maternal-Fetal Medicine); Mari G, Norton ME, Stone J, Berghella V, Sciscione AC, Tate D, Schenone MH (2015b) Society of Maternal-Fetal Medicine (SFMF) Clinical Guideline #8: the fetus at risk for anemia – diagnosis and management. Am J Obstet Gynecol 212: 697–710

Smits-Wintjens VE, Rath ME, Lindenburg IT, Oepkes D, van Zwet EW, Walther FJ, Lopriore E (2012) Cholestasis in neonates with red cell alloimmune hemolytic disease: incidence, risk factors and outcome. Neonatology 101: 306–310

Swartz AE, Ruma MS, Kim E, Herring AH, Menard MK, Moise KJ Jr (2009) The effect of fetal heart rate on the peak systolic velocity of the fetal middle cerebral artery. Obstet Gynecol 113: 1225–1229

Takagi K, Tanaka H, Nishijima S, Masaoka N, Miyake Y, Sakata H, Satoh K (1989) Fetal blood values by percutaneous umbilical blood sampling. Fetal Ther 4: 152–160

Tiblad E, Kublickas M, Ajne G, Bui TH, Ek S, Karlsson A, Wikman A, Westgren M (2011) Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm. Fetal Diagn Ther 30: 266–273

Tiller H, Kamphuis MM, Flodmark O, Papadogiannakis N, David AL, Sainio S, Koskinen S, Javela K, Wikman AT, Kekomaki R, Kanhai HH, Oepkes D, Husebekk A, Westgren M (2013) Fetal intracranial haemorrhages caused by fetal and neonatal alloimmune thrombocytopenia: an observational cohort study of 43 cases from an international multicentre registry. BMJ Open Mar 22: 3(3). pii: e002490

Tiller H, Husebekk A, Skogen B, Kjeldsen-Kragh J, Kjaer M (2016) True risk of fetal/neonatal alloimmune thrombocytopenia in subsequent pregnancies: a prospective observational follow-up study. BJOG 123: 738–44

Traeger-Synodinos J, Harteveld CL, Old JM, Petrou M, Galanello R, Giordano P, Angastioniotis M, De la Salle B, Henderson S, May A; EMQN haemoglobinopathies best practice meeting (2015) EMQN Best Practice Guidelines for molecular and haematology methods for carrier identification and prenatal diagnosis of the haemoglobinopathies. Eur J Hum Genet 23: 426–437

van den Akker ES, de Haan TR, Lopriore E, Brand A, Kanhai HH, Oepkes D (2008) Severe fetal thrombocytopenia in Rhesus D alloimmunized pregnancies. Am J Obstet Gynecol 199: 387.e1–4

van der Schoot CE, Tax GH, Rijnders RJ, de Haas M, Christiaens GC (2003) Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed. Transfus Med Rev 17: 31–44

van Dongen H, Klumper FJ, Sikkel E, Vandenbussche FP, Oepkes D (2005) Noninvasive tests to predict fetal anemia in Kell-alloimmunized pregnancies. Ultrasound Obstet Gynecol 25: 341–315

van Kamp IL, Klumper FJ, Oepkes D, Meerman RH, Scherjon SA, Vandenbussche FP, Kanhai HH (2005) Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization. Am J Obstet Gynecol 192: 171–177

van Winden KR, Quintero RA, Kontopoulos EV, Korst LM, Llanes A, Chmait RH (2015) Pre-operative twin anemia/polycythemia in the setting of twin-twin transfusion syndrome (TTTS). Fetal Diagn Ther 37: 274–280

Vandenbussche FPHA, Brand A, Kanhai HHH (2011) Fetal thrombocytopenia. In: James D, Steer PJ, Weiner CP, Gonik B, Crowther CA, Robson SC (eds) High risk pregnancy: management options, 4th ed. Saunders, St. Louis, p 229–237

Vogel M, McElhinney DB, Wilkins-Haug LE, Marshall AC, Benson CB, Juraszek AL, Silva V, Lock JE, Marx GR, Tworetzky W (2011) Aortic stenosis and severe mitral regurgitation in the fetus resulting in giant left atrium and hydrops: pathophysiology, outcomes, and preliminary experience with pre-natal cardiac intervention. J Am Coll Cardiol 57: 348–355

Weiner CP (2011) Fetal hemolytic disease. In: James D, Steer PJ, Weiner CP, Gonik B, Cowther CA, Robson SC (eds) High risk pregnancy: management options, 4th ed. Saunders, St. Louis, p 209–227

Winkelhorst D, Murphy MF, Greinacher A, Shehata N, Bakchoul T, Massey E, Baker J, Lieberman L, Tanael S, Hume H, Arnold DM, Baidya S, Bertrand G, Bussel J, Kjaer M, Kaplan C, Kjeldsen-Kragh J, Oepkes D, Ryan G (2017) Antenatal management in fetal and neonatal alloimmune thrombocytopenia: a systematic review. Blood 129: 1538–1547

Witlox RS, Lopriore E, Oepkes D, Walther FJ (2011) Neonatal outcome after prenatal interventions for congenital lung lesions. Early Hum Dev 87: 611–618

Wylie BJ, D’Alton ME (2010) Fetomaternal hemorrhage. Obstet Gynecol 115: 1039–1051

Yang YS, Ma GC, Shih JC, Chen CP, Chou CH, Yeh KT, Kuo SJ, Chen TH, Hwu WL, Lee TH, Chen M (2012) Experimental treatment of bilateral fetal chylothorax using in-utero pleurodesis. Ultrasound Obstet Gynecol 39: 56–62

Yinon Y, Grisaru-Granovsky S, Chaddha V, Windrim R, Seaward PG, Kelly EN, Beresovska O, Ryan G (2010) Perinatal outcome following fetal chest shunt insertion for pleural effusion. Ultrasound Obstet Gynecol 36: 58–64

Yougbaré I, Lang S, Yang H, Chen P, Zhao X, Tai WS, Zdravic D, Vadasz B, Li C, Piran S, Marshall A, Zhu G, Tiller H, Killie MK, Boyd S, Leong-Poi H, Wen XY, Skogen B, Adamson SL, Freedman J, Ni H (2015) Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage. J Clin Invest 125: 1545–1556

Titel: Hydrops fetalis, Anämie und Thrombozytopenie
verfasst von: Prof. Dr. med. U. Gembruch
Verlag: Springer Berlin Heidelberg
Buch: Ultraschalldiagnostik in Geburtshilfe und Gynäkologie
Print ISBN: 978-3-662-53661-2

Electronic ISBN: 978-3-662-53662-9

Copyright-Jahr: 2018
DOI: https://doi.org/10.1007/978-3-662-53662-9_24

Springerpflege

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten